| Particulars |
|
|
|
| Company Name
| Concord Biotech Ltd
| Year End
| 202503
|
| Full Year |
| Equity (₹ Cr.) |
10.46 |
B.V. (₹) |
174.50 |
| Sales(₹ Cr.) |
1,200.09 |
NP (₹ Cr.) |
356.39 |
| NP Var% |
21.00 |
Div% |
875.00 |
| CPS(₹) |
39.30 |
EPS (₹) |
34.10 |
| Traded Value(₹ Lakhs) |
195.11 |
52 Week High |
2,150.00 |
| 52 Week Low |
987.00 |
Price BSE |
1,071.00 |
| Price NSE |
1,072.00 |
Market Capital (₹ Cr.) |
11,204.92 |
| P/C Ratio |
27.30 |
P/E Ratio |
31.40 |
| Price Vs.BV |
6.14 |
|
| Latest Quarter |
| Year End |
202512 |
Sales (₹ Cr.) |
278.13 |
| NP(₹ Cr.) |
70.24 |
NP Var % |
-5.00 |
| Trailing Twelve Months |
| Year End |
202512 |
Sales |
1,085.75 |
| OPM |
42.50 |
NP |
328.71 |
| NP Var% |
-3.23 |
EPS |
30.36 |
| PE |
35.28 |
|
|